Cochrane · systematic review · CD011476

Liposomal bupivacaine peripheral nerve block for the management of postoperative pain

Hamilton, TW, Athanassoglou, V, Trivella, M, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
9
current version
GRADE rated
3
No studies
6
Included studies
NR
No studies 6 · 66.7%Ungraded 0 · 0%Very low 3 · 33.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain

Population: adults aged ≥ 18 years undergoing elective surgery at any surgical site
9 questions
OutcomeEffectEvidenceStatus / GRADE
Cumulative pain score from the end of operation (0 hours) to 72 hours
no estimate extractedNRNo studies
Serious adverse events
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision, inconsistency
Mean pain score at 12, 24, 48, 72, and 96 hours following surgery
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision, inconsistency
Time to first postoperative opioid dose
no estimate extractedNRNo studies
Total postoperative opioid consumption over first 72 hours
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision, inconsistency
Percentage of participants not requiring postoperative opioids over initial 72 hours
no estimate extractedNRNo studies
Health economic assessment
no estimate extractedNRNo studies
Incidence of adverse events within 30 days of surgery
no estimate extractedNRNo studies
Patient‐reported outcomes
no estimate extractedNRNo studies